Yamada J, Ksander B R, Streilein J W
Schepens Eye Research Institute and the Department of Ophthalmology, Harvard Medical School, Boston, Massachusetts 02114-2500, USA.
Invest Ophthalmol Vis Sci. 2001 Feb;42(2):386-92.
To determine whether cytotoxic T cells of the direct alloreactive type are activated and responsible for early, acute failure of orthotopic corneal allografts observed in eyes of C57BL/6 but not of BALB/c mice.
Corneas from BALB/c and BALB.B mice were placed orthotopically in eyes of C57BL/6 and beta-2 microglobulin knockout mice (deficient in CD8(+) cytotoxic T cells). Graft fates were assessed clinically, and the T lymphocytes of recipients were assayed for the capacity to lyse target cells bearing donor major (MHC) and/or minor histocompatibility (minor H) antigens (direct and indirect pathways, respectively). RESULTS. Similar to BALB/c recipients, C57BL/6 mice with rejected cornea allografts acquired donor minor H-specific T cells. Unlike BALB/c recipients, C57BL/6 mice-both rejectors and acceptors-acquired donor MHC-specific T cells. beta-2 Microglobulin knockout mice showed rejection of corneal allografts in a manner indistinguishable from C57BL/6 mice, including early, acute rejection, yet T cells from beta-2 microglobulin knockout recipients of corneal allografts displayed no cytotoxic T cells specific for either donor MHC or minor H alloantigens.
Although C57BL/6 mice acquired donor MHC-specific cytotoxic T cells (direct alloreactive cells), neither these cells nor donor minor H-specific cytotoxic T cells (indirect alloreactive cells) play any essential role in corneal allograft rejection, including the early acute failure uniquely observed in C57BL/6 eyes.
确定直接同种异体反应型细胞毒性T细胞是否被激活,并对在C57BL/6小鼠而非BALB/c小鼠眼中观察到的原位角膜同种异体移植早期急性失败负责。
将BALB/c和BALB.B小鼠的角膜原位植入C57BL/6和β2微球蛋白敲除小鼠(缺乏CD8(+)细胞毒性T细胞)的眼中。临床评估移植物的命运,并检测受体的T淋巴细胞裂解携带供体主要(MHC)和/或次要组织相容性(次要H)抗原的靶细胞的能力(分别为直接和间接途径)。结果。与BALB/c受体相似,角膜同种异体移植被排斥的C57BL/6小鼠获得了供体次要H特异性T细胞。与BALB/c受体不同,C57BL/6小鼠(包括排斥者和接受者)都获得了供体MHC特异性T细胞。β2微球蛋白敲除小鼠以与C57BL/6小鼠无法区分的方式表现出角膜同种异体移植排斥,包括早期急性排斥,然而角膜同种异体移植的β2微球蛋白敲除受体的T细胞对供体MHC或次要H同种异体抗原均未显示细胞毒性T细胞。
尽管C57BL/6小鼠获得了供体MHC特异性细胞毒性T细胞(直接同种异体反应细胞),但这些细胞和供体次要H特异性细胞毒性T细胞(间接同种异体反应细胞)在角膜同种异体移植排斥中均未发挥任何重要作用,包括在C57BL/6眼中独特观察到的早期急性失败。